Chinese Journal of Mycology 2013, Vol. 8 Issue (2): 124-128.
ZHAO Lan-xue1,2, LI De-dong2, WANG Yan2, JIANG Yuan-ying2
Received:2012-10-11
Online:2013-04-28
Published:2013-04-28
CLC Number:
ZHAO Lan-xue, LI De-dong, WANG Yan, JIANG Yuan-ying. An update of antifungals functioning on inhibiting Candida albicans biofilm formation[J]. Chinese Journal of Mycology, 2013, 8(2): 124-128.
Add to citation manager EndNote|Ris|BibTeX
URL: http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/
http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/Y2013/V8/I2/124
| [1] Azie N, Neofytos D, M, et al. The PATH (Prospective Antifungal Therapy) All iance® registry and invasive fungal infections: update 2012. Diagnostic Microbiology and Infectious Disease. 2012, 73(4):293-300. [2] Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance[J]. Journal of bacteriology, 2001, 183(18):5385-5394. [3] Tobudic S, Lassnigg A, Kratzer C, et al. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases[J]. Mycoses, 2010, 53(3):208-214. [4] Kuhn DM, George T, Chandra J, et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins[J]. Antimicrobial agents and chemotherapy, 2002, 46(6):1773-1780. [5] Ramage G, Jose A, Coco B, et al. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro[J]. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2011, 111(4): 456-460. [6] Donlan RM and Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms[J]. Clinical microbiology reviews, 2002, 15(2):167-193. [7] Perumal P, Mekala S and Chaffin WLJ. Role for cell density in antifungal drug resistance in Candida albicans biofilms[J]. Antimicrobial agents and chemotherapy, 2007, 51(7):2454-2463. [8] Silva S, Pires P, Monteiro DR, et al. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic[J]. Medical Mycology, 2013, 51(2):178-184. [9] Soustre J, Rodier MH, Imbert-Bouyer S, et al. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins[J]. Journal of Antimicrobial Chemotherapy, 2004, 53(3):522-525. [10] Bachmann SP, VandeWK, Ramage G, et al. In vitro activity of caspofungin against Candida albicans biofilms[J]. Antimicrobial agents and chemotherapy, 2002, 46(11):3591-3596. [11] Andriole V.T. Current and future antifungal therapy: new targets for antifungal therapy[J]. International journal of antimicrobial agents, 2000, 16(3):317-321. [12] Cateau E, Rodier MH and Imbert C. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth[J]. Journal of Antimicrobial Chemotherapy, 2008, 62(1):153-155. [13] Vediyappan G, Rossignol T and d'Enfert C. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans[J]. Antimicrobial agents and chemotherapy, 2010, 54(5):2096-2111. [14] Hawser SP and Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro[J]. Antimicrobial agents and chemotherapy, 1995, 39(9):2128-2131. [15] Sanglard D, Kuchler K, Ischer F, et al. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters[J]. Antimicrobial agents and chemotherapy, 1995, 39(11):2378-2386. [16] Katragkou Α, Chatzimoschou A, Simitsopoulou M, et al. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms[J]. Antimicrobial agents and chemotherapy, 2008, 52(1):357-360. [17] Cao YY, Dai BD, Wang Y, et al. In vitro activity of baicalein against Candida albicans biofilms[J]. International journal of antimicrobial agents, 2008, 32(1):73-77. [18] Messier C and Grenier D. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans[J]. Mycoses, 2011, 54(6):e801-e806. [19] 汪长中,程惠娟,官妍,等. 苦参碱对体外白念珠菌生物膜抑制作用[J]. 中国公共卫生, 2008, 12(12):1491-1492. [20] 汪长中,程惠娟,官妍, 等. 黄连解毒汤对体外白念珠菌生物膜形成的影响[J]. 热带病与寄生虫学, 2007, 5(2):82-84. [21] Rukayadi Y, Han S, Yong D, et al. In vitro activity of xanthorrhizol against Candida glabrata,C.guilliermondii,and C.parapsilosis biofilms[J]. Medical Mycology, 2011, 49(1):1-9. [22] Braga PC, Culici M, Alfieri M, et al. Thymol inhibits Candida albicans biofilm formation and mature biofilm[J]. International journal of antimicrobial agents, 2008, 31(5):472-477. [23] Dalleau S, Cateau E, Bergès T, et al. In vitro activity of terpenes against Candida biofilms[J]. International journal of antimicrobial agents, 2008, 31(6):572-576. [24] Taweechaisupapong S, Singhara S, Lertsatitthanakorn P, et al. Antimicrobial effects of Boesenbergia pandurata and Piper sarmentosum leaf extracts on planktonic cells and biofilm of oral pathogens[J]. Pak. J. Pharm. Sci, 2010, 23(2):224-231. [25] Thaweboon S and Thaweboon B. In vitro antimicrobial activity of Ocimum americanum L. essential oil against oral microorganisms[J]. Southeast Asian Journal of Tropical Medicine and Public Health, 2009, 40(5):1025. [26] Sudjana AN, Carson CF, Carson KC, et al. Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil[J]. Medical Mycology, 2012,50(8):1-8. [27] Hendry ER, Worthington T, Conway BR, et al. Antimicrobial efficacy of eucalyptus oil and 1, 8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures[J]. Journal of Antimicrobial Chemotherapy, 2009, 64(6):1219-1225. [28] Rabea EI, Badawy MET, Stevens CV, et al. Chitosan as antimicrobial agent: applications and mode of action[J]. Biomacromolecules, 2003, 4(6):1457-1465. [29] Martinez LR, Mihu MR, Tar M, et al. Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model[J]. Journal of Infectious Diseases, 2010, 201(9):1436-1440. [30] Coleman JJ, Okoli I, Tegos GP, et al. Characterization of plant-derived saponin natural products against Candida albicans[J]. ACS chemical biology, 2010, 5(3):321-332. [31] Evensen N and Braun P. The effects of tea polyphenols on Candida albicans: inhibition of biofilm formation and proteasome inactivation[J]. Canadian journal of microbiology, 2009, 55(9):1033-1039. [32] Xie C and Lou H. Chemical constituents from the Chinese bryophytes and their reversal of fungal resistance[J]. Current Organic Chemistry, 2008, 12(8):619-628. [33] Lu ZQ, Fan PH, Ji M, et al. Terpenoids and bisbibenzyls from Chinese liverworts Conocephalum conicum and Dumortiera hirsuta[J]. Journal of Asian natural products research, 2006, 8(1-2):187-192. [34] Cheng A, Sun L, Wu X, et al. The inhibitory effect of a macrocyclic bisbibenzyl riccardin D on the biofilms of Candida albicans[J]. Biological and Pharmaceutical Bulletin, 2009, 32(8):1417-1421. [35] Bachmann SP, Ramage G, Vande WK, et al. Antifungal combinations against Candida albicans biofilms in vitro[J]. Antimicrobial agents and chemotherapy, 2003, 47(11):3657-3659. [36] Tobudic S, Kratzer C, Lassnigg A, et al. In vitro activity of antifungal combinations against Candida albicans biofilms[J]. Journal of Antimicrobial Chemotherapy, 2010, 65(2):271-274. [37] Pai MP. Antifungal combinations against simulated Candida albicans endocardial vegetations[J]. Antimicrobial agents and chemotherapy, 2009, 53(6):2629-2631. [38] Uppuluri P, Nett J, Heitman J, et al. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms[J]. Antimicrobial agents and chemotherapy, 2008, 52(3):1127-1132. [39] Miceli MH, Bernardo SM and Lee SA. In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms[J]. International journal of antimicrobial agents, 2009, 34(4):326-332. [40] Ku TSN, Palanisamy SKA and Lee SA. Susceptibility of Candida albicans biofilms to azithromycin, tigecycline and vancomycin and the interaction between tigecycline and antifungals[J]. International journal of antimicrobial agents, 2010, 36(5):441-446. [41] Shi W, Chen Z, Chen X, et al. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents[J]. FEMS yeast research, 2010, 10(7):885-893. |
| [1] | YANG Jing-xian, SHAO Dong-hua, GUO Li-na, LIU Jing, Xu Ying-chun, LIANG Guo-wei. Species distribution and antifungal susceptibility test of invasive Candida infection in a hospital in Beijing [J]. Chinese Journal of Mycology, 2020, 15(6): 359-363,370. |
| [2] | LI Ying, WANG He, ZHANG Ge, LIU Wen-jing, XU Ying-chun. Comparative evaluation of Sensititre YeastOne colorimetric panel with broth microdilution method for in vitro antifungal susceptibility testing of Aspergillus [J]. Chinese Journal of Mycology, 2020, 15(4): 197-201. |
| [3] | QU Xin-yao, LI Shan-shan, QU Yue, Abdulhakim Salad Nageye, SONG Yang, CUI Yan. In vitro antifungal susceptibility of 10 Chinese herbal monomers against Sporothrix globosa [J]. Chinese Journal of Mycology, 2020, 15(3): 145-149. |
| [4] | ZHANG Wen, LUO Ying, GUO Cheng-jie, XU Ying-chun, XIAO Meng, LEI Cheng-bin, ZHAO Yan, BI Lei. Clinical characteristics and pathogen of patients with candidemia [J]. Chinese Journal of Mycology, 2020, 15(3): 154-160. |
| [5] | ZHAO De-jun, YANG Lin. Analysis of strain distribution and drug resistance of Candida vaginal isolates in women from a region of Guizhou Province [J]. Chinese Journal of Mycology, 2020, 15(2): 83-87. |
| [6] | KAN Si-yue, CAI Qing, JING Yun, CHEN Wei, HU Su-quan, YANG Lian-juan, LIU Wei-da. Study on mucocutaneous candidiasis in infants: the clinical characteristics and in vitro susceptibility of pathogenic yeasts [J]. Chinese Journal of Mycology, 2020, 15(2): 97-100. |
| [7] | FAN Xin, GUO Li-na, YANG Yang, ZHANG Ge, DUAN Si-meng, ZHANG Jing-jia, XU Ying-chun, YANG Chun-xia. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections [J]. Chinese Journal of Mycology, 2020, 15(1): 10-14. |
| [8] | ZHANG Jing-xia, CUI En-bo, ZHANG Ju-ling, GUO Li-na, XU Ying-chun, QU Fen. Clinical distribution of yeast infection in aseptic parts of patients with liver disease and sensitivity analysis of antifungal drugs [J]. Chinese Journal of Mycology, 2020, 15(1): 15-21. |
| [9] | MA Sheng-yan, ZHOU Xue-zhang. Study on the effect of flunixin meglumine on the biofilm formation of Candida krusei and on the combination with azoles [J]. Chinese Journal of Mycology, 2020, 15(1): 31-36. |
| [10] | ZHANG Xiu-jun, GUO Yan-yang, ZHU Zhen-lai, XUE Xiao-wen, MA Cui-ling, WANG Gang, FU Meng. Effects of NETs on Trichophyton verrucosum infection [J]. Chinese Journal of Mycology, 2019, 14(6): 326-331. |
| [11] | LIU Wen-jing, SUN Hong-li, ZHANG Xiao-jiang, YANG Wen-hang, XIAO Meng, WANG Yao, YANG Qi-wen, DOU Hong-tao, WANG He, ZHAO Ying, GUO Li-na, LIU Ya-li, ZHANG Li, ZHU Ren-yuan, XU Ying-chun. Analysis the pathogen distribution and drug susceptibility of yeast bloodstream infection in Peking Union Medical College Hospital from 2014 to 2018 [J]. Chinese Journal of Mycology, 2019, 14(6): 357-361. |
| [12] | YU Shu-ying, ZHANG Li, LI Ying, XU Ying-chun. Evaluation of the in vitro antifungal activity of the domestic caspofungin against clinical Aspergillus isolates [J]. Chinese Journal of Mycology, 2019, 14(3): 141-146. |
| [13] | DENG Jie-hua, LI JI-hong, QI Xiao-ming, WANG Gang-sheng. Comparison of sensitivity of cinnamaldehyde and caspofungin to Aspergillus oryzae and their effects on cell wall of Aspergillus fumigatus [J]. Chinese Journal of Mycology, 2018, 13(6): 345-349. |
| [14] | ZHOU Ya-bin, WANG Qian, ANG Hao, WAN Zhe, LI Ruo-yu, Liu Wei. In vitro antifungal activity of domestic amphotericin B and other common antifungal agents against pathogenic fungi isolated from invasive fungal disease [J]. Chinese Journal of Mycology, 2018, 13(5): 277-282. |
| [15] | ZHOU Xin, MA Xiao-ling, YE Shu-lai, LU Huai-wei, WANG Ying. A rarecase report of encephalopyosis induced by Scedosporium apiospermum: identification of causativeagent and antifungal susceptibility testing in vitro [J]. Chinese Journal of Mycology, 2018, 13(5): 294-296,304. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
